According to GuruFocus Insider Data, the recent CFO buys were: QTS Realty Trust Inc. (QTS, Financial), Melinta Therapeutics Inc. (MLNT, Financial), and Kellogg Co (K, Financial).
QTS Realty Trust Inc.: CFO Jeffrey H. Berson bought 15,000 shares
CFO Jeffrey H. Berson bought 15,000 shares for $34.89 per share on May 21. Since then, the stock price has increased by 10.55%. QTS Realty Trust Inc. has a market cap of $1.97 billion and its shares were traded around $38.57. The company has a P/S ratio of 4.59. The trailing 12-month dividend yield of QTS Realty Trust Inc. stocks is 4.10%, while the forward dividend yield is 4.35%. Over the past 5 years, QTS Realty Trust Inc. had an annual average earnings growth of 13.70%.
QTS Realty Trust announced its first-quarter results with revenues of $113.70 million and gross profit of $73.05 million; the net loss was $223,000. The 2017 total revenue was $446.51 million, an 11% increase from the 2016 total revenue. The 2017 gross profit was $281.34 million, a 9% increase from the 2016 gross profit. The 2017 net income was $1.28 million.
CEO Chad L. Williams bought 50,000 shares for $35.68 per share on May 23. Since then, the stock price has increased by 8.1%. Chief People Officer Steven C Bloom bought 1,000 shares for $35.08 per share on May 23. Since then, the stock price has increased by 9.95%. Director Philip P Trahanas bought 60,000 shares for $34.72 per share on May 21. Since then, the stock price has increased by 11.09%.
.
Melinta Therapeutics Inc.: CFO Paul Estrem bought 10,000 shares
CFO Paul Estrem bought 10,000 shares for $5 per share on May 29. Since then, the stock price has increased by 33%. Melinta Therapeutics Inc. has a market cap of $372.460 million and its shares were traded around $6.65. The company has a P/S ratio of 3.50.
Melinta Therapeutic announced its first-quarter results with revenues of $14.84 million and gross profit of $7.16 million; the net loss was $29.43 million. The 2017 total revenue and gross profit was $33.86 million, while the net loss was $58.92 million.
Director David Zaccardelli bought 40,000 shares for $5 per share on May 29. Since then, the stock price has increased by 33%. Chief Scientific Officer Erin Duffy bought 4,000 shares for $5 per share on May 29. Since then, the stock price has increased by 33%. See Remarks Daniel Mark Wechsler bought 50,000 shares for $5 per share on May 29. Since then, the stock price has increased by 33%.
Kellogg Co: CFO Fareed A Khan bought 8,080 shares
CFO Fareed A Khan bought 8,080 shares for $61.78 per share on May 22. Since then, the stock price has increased by 3.32%. Kellogg Co has a market cap of $22.14 billion and its shares were traded around $63.83. The company has a P/E ratio of 15.38 and P/S ratio of 1.71. The trailing 12-month dividend yield of Kellogg Co stocks is 3.36%, while the forward dividend yield is 3.35%.
Kellogg Co announced its first-quarter results with revenues of $3.4 billion and gross profit of $1.25 billion; the net income was $444 million. The 2017 total revenue was $12.92 billion, a 0.7% decrease from the 2016 total revenue. The 2017 gross profit was $5.02 billion, a 6% increase from the 2016 gross profit. The 2017 net income was $1.27 billion.
Senior Vice President Amit Banati sold 1,992 shares for $65.03 per share on May 29. Since then, the stock price has decreased by 1.85%. 10% Owner W K Foundation Trust Kellogg sold 175,000 shares for $61.37 per share on May 16. Since then, the stock price has increased by 4.01%.
Disclosure: none
